Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
FTY720 attenuates excitotoxicity and neuroinflammation.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Olfactory dysfunction in multiple sclerosis.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
Freedom from disease activity in multiple sclerosis.
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Ten-year follow-up shows efficacy of Sanofi's MS drug Lemtrada
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Multiple sclerosis: basic knowledge and new insights in perioperative management.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Diverse functional roles of lipocalin-2 in the central nervous system.
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.

Pages